Are the New Nucleos(t)ide Analogs Better than the Old Nucleos(t)ide Analogs?

被引:0
作者
Choi, Jonggi [1 ]
Choi, Won-Mook [1 ]
Lim, Young-Suk [1 ]
机构
[1] Univ Ulsan, Asan Med Ctr, Dept Gastroenterol, Coll Med, 88, Olymp Ro 43-gil, Seoul 05505, South Korea
关键词
Lamivudine; Adefovir; Entecavir; Tenofovir; Hepatitis B; Hepatocellular carcinoma; CHRONIC HEPATITIS-B; TENOFOVIR DISOPROXIL FUMARATE; HEPATOCELLULAR-CARCINOMA; DOUBLE-BLIND; ANTIVIRAL THERAPY; VIRUS INFECTION; ENTECAVIR; ALAFENAMIDE; RESISTANCE; PHASE-3;
D O I
10.1016/j.cld.2023.05.005
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:809 / 818
页数:10
相关论文
共 50 条
  • [31] Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B
    Ogawa, Eiichi
    Nomura, Hideyuki
    Nakamuta, Makoto
    Furusyo, Norihiro
    Koyanagi, Toshimasa
    Dohmen, Kazufumi
    Ooho, Aritsune
    Satoh, Takeaki
    Kawano, Akira
    Kajiwara, Eiji
    Takahashi, Kazuhiro
    Azuma, Koichi
    Kato, Masaki
    Shimoda, Shinji
    Hayashi, Jun
    [J]. LIVER INTERNATIONAL, 2020, 40 (07) : 1578 - 1589
  • [32] Current Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B
    Kim, Soon Sun
    Cheong, Jae Youn
    Cho, Sung Won
    [J]. GUT AND LIVER, 2011, 5 (03) : 278 - 287
  • [33] Therapy with nucleos(t)ide analogues: Current role in dialysis patients
    Fabrizi, Fabrizio
    Messa, Piergiorgio
    Dixit, Vivek
    Martin, Paul
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2010, 33 (06) : 329 - 338
  • [34] Tenofovir disoproxil fumarate for patients with chronic hepatitis B who suboptimal response to non-tenofovir disoproxil fumarate nucleos(t)ide analogs therapy
    Chen, Kwei-Ming
    Chang, Chi-Hsien
    Lee, Jyong-Hong
    Yang, Chi-Chieh
    [J]. ADVANCES IN DIGESTIVE MEDICINE, 2020, 7 (04) : 207 - 213
  • [35] Prevalence and Associated Factors of Low-Level Viremia in Chronic Hepatitis B Patients After Long-Term Therapy with Nucleos(t)ide Analogs
    Han, Jiajia
    Guo, Yifei
    Zhang, Xueyun
    Zhang, Yao
    Sun, Jian
    He, Jingjing
    Mao, Richeng
    Huang, Yuxian
    Zhang, Jiming
    [J]. TURKISH JOURNAL OF GASTROENTEROLOGY, 2023, 34 (01) : 53 - 61
  • [36] Value of autotaxin for hepatocellular carcinoma risk assessment in chronic hepatitis B patients treated with nucleos(t)ide analogs
    Hiyama, Yuichi
    Fujino, Hatsue
    Namba, Maiko
    Fujii, Yasutoshi
    Uchikawa, Shinsuke
    Ono, Atsushi
    Nakahara, Takashi
    Murakami, Eisuke
    Kawaoka, Tomokazu
    Miki, Daiki
    Tsuge, Masataka
    Oka, Shiro
    [J]. HEPATOLOGY RESEARCH, 2024, 54 (11) : 981 - 992
  • [37] Effectiveness of tenofovir alafenamide for chronic hepatitis B patients with a poor response to the previously used nucleos(t)ide analogs
    Daiki Yamashige
    Tetsuya Hosaka
    Fumitaka Suzuki
    Shunichiro Fujiyama
    Yusuke Kawamura
    Hitomi Sezaki
    Norio Akuta
    Masahiro Kobayashi
    Yoshiyuki Suzuki
    Satoshi Saitoh
    Yasuji Arase
    Kenji Ikeda
    Mariko Kobayashi
    Hiromitsu Kumada
    [J]. Journal of Gastroenterology, 2021, 56 : 1008 - 1021
  • [38] Nucleos(t)ide analogues for hepatitis B virus: Strategies for long-term success
    Chien, Rong-Nan
    Liaw, Yun-Fan
    [J]. BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2008, 22 (06) : 1081 - 1092
  • [39] HBsAg and HBcrAg as predictors of HBeAg seroconversion in HBeAg-positive patients treated with nucleos(t)ide analogues
    Wang, B.
    Carey, I.
    Bruce, M.
    Montague, S.
    Dusheiko, G.
    Agarwal, K.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2018, 25 (08) : 886 - 893
  • [40] Long-term outcomes of hepatitis B virus-related cirrhosis treated with nucleos(t)ide analogs
    Tsai, Ming-Chao
    Chen, Chien-Hung
    Hu, Tsung-Hui
    Lu, Sheng-Nan
    Lee, Chuan-Mo
    Wang, Jing-Houng
    Hung, Chao-Hung
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2017, 116 (07) : 512 - 521